2012•Chinese and Foreign Medical ResearchRequires access

The clinical analysis of the efficacy for refined insulin plus glipizide in the treatment of type 2 diabetes

HU Xiong-fen

Open publisher page 0 citations

Abstract

Objective:To investigate the clinical efficacy for refined insulin plus glipizide in the treatment of type 2 diabetes. Methods:130 cases of type 2 diabetes were randomly divided into the comparability of two groups of 65 cases. They were respectively given the joint the Gan arginine joint glipizide treatment,and Novolin N glipizide treatment. The treatment effect of the two groups was compared. Results: After 12 weeks of treatment, the blood glucose rate of the observation group was significantly higher than the control group. The event of nocturnal hypoglycemia was signifi- cantly lower than the control group,the difference for the two groups of patients was statistically significant(P 0. 05) . Conclusion: The use of fine insulin joint grid glipizide treatment of type 2 diabetes is safe and effective.

About this research paper

What this paper is about

Objective:To investigate the clinical efficacy for refined insulin plus glipizide in the treatment of type 2 diabetes. Methods:130 cases of type 2 diabetes were randomly divided into the comparability of two groups of 65 cases. They were respectively given the joint the Gan arginine joint glipizide treatment,and Novolin N glipizide treatment. The treatment effect of the two groups was compared. Results: After 12 weeks of treatment, the blood glucose rate of the observation group was significantly higher than the control group. The event of nocturnal hypoglycemia was signifi- cantly lower than the control group,the difference for the two groups of patients was statistically significant(P 0. 05) . Conclusion: The use of fine insulin joint grid glipizide treatment of type 2 diabetes is safe and effective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the clinical efficacy for refined insulin plus glipizide in the treatment of type 2 diabetes. Methods:130 cases of type 2 diabetes were randomly divided into the comparability of two groups of 65 cases. They were respectively given the joint the Gan arginine joint glipizide treatment,and Novolin N glipizide treatment. The treatment effect of the two groups was compared. Results: After 12 weeks of treatment, the blood glucose rate of the observation group was significantly higher than the control group. The event of nocturnal hypoglycemia was signifi- cantly lower than the control group,the difference for the two groups of patients was statistically significant(P 0. 05) . Conclusion: The use of fine insulin joint grid glipizide treatment of type 2 diabetes is safe and effective.

Key concepts: Glipizide, Medicine, Type 2 diabetes, Hypoglycemia, Internal medicine, Diabetes mellitus, Insulin, Gliclazide

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical analysis of the efficacy for refined insulin plus glipizide in the treatment of type 2 diabetes — Research Paper | ScholarLens